In cancer, RKIP expression is reported to be low, and several studies showed that it could behave as a negative prognostic marker in prostate cancer, breast, colorectal, gastric, pancreatic, gliomas, and hepatocellular carcinoma revealing this gene as a tumor suppressor [21, 23–30]. The gene discussed is PEBP1; the disease is cancer.